Perkin Elmer To Sell Analytical Instruments Division

PerkinElmer Instruments, Inc.ing a strategic review, <%=company%> (PE) has confirmed its decision to sell the Company's Analytical Instruments Division and as a result, the financial results of Analytical Instruments will be reported as a discontinued operation for the quarter ended Dec. 31, 1998. The investment banker Warburg Dillon Read LLC has been retained to explore various alternatives for the Analytical Instruments Division and will continue this process to achieve a timely sale of the business unit at an appropriate price.

Tony L. White, chairman, president and CEO of PE, explained that the Company set out three years ago to transform its operations, to become a source for genetic information driving new applications for life science discoveries. He called the decision to sell Analytical Instruments, "another milestone in that transformation."

"With the formation of Celera Genomics and major investments in PE Biosystems, combined with the decision to sell Analytical Instruments, we have completely redefined the Company," White said. "Our objective is to accelerate the shift of genetic analysis from academia to more robust commercial applications. Completing the sale of the Analytical Instruments Division will allow us to allocate all of our time, capital, and management attention to fulfilling that vision."

PE's Analytical Instruments Division had sales of $609 million during fiscal 1998 and is a leader in supplying a broad range of instruments to the pharmaceutical, environmental, food, chemical, petrochemical, and related industries.

<%=company%>, For more information, call 800-762-6923.